Beam Therapeutics (BEAM) EPS (Basic) (2019 - 2026)
Beam Therapeutics (BEAM) posted quarterly EPS (Basic) of -$0.91 for Q1 2026, up 25.82% year-over-year from -$0.73 in Q1 2025, and down 136.98% quarter-over-quarter from $2.47 in Q4 2025.
Powered by 
Analysis
Beam Therapeutics (BEAM) EPS (Basic) (2019 - 2026) Analysis & Trends
Beam Therapeutics (BEAM) has reported EPS (Basic) for 8 consecutive years, with -$0.91 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 25.82% year-over-year to -$0.91; the TTM figure through Mar 2026 stood at -$0.63 (up 85.66% YoY), while the FY2025 annual figure was -$0.81, up 82.33% from the prior year.
- EPS (Basic) slipped to -$0.91 in Q1 2026 per BEAM's latest filing, from $2.47 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.47 in Q4 2025 and bottomed at -$1.56 in Q3 2022.
- Historically, EPS (Basic) has averaged -$0.72 across 5 years, with a median of -$1.1 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 267.73% — and 2023, when it surged 437.92%.
- Beam Therapeutics' EPS (Basic) stood at -$0.55 in 2022, then soared by 437.92% to $1.85 in 2023, then plunged by 159.31% to -$1.1 in 2024, then surged by 325.02% to $2.47 in 2025, then slumped by 136.98% to -$0.91 in 2026.
- Business Quant data shows BEAM's EPS (Basic) at -$0.91 in Q1 2026, $2.47 in Q4 2025, and -$1.1 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Beam Therapeutics | 3.10 Bn | 3.10 Bn | - | -1.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.18 |
| Mar 31, 2026 | -0.91 |
| Dec 31, 2025 | 2.47 |
| Sep 30, 2025 | -1.10 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -1.23 |
| Dec 31, 2024 | -1.10 |
| Sep 30, 2024 | -1.17 |
| Jun 30, 2024 | -1.11 |
| Mar 31, 2024 | -1.21 |
| Dec 31, 2023 | 1.85 |
| Sep 30, 2023 | -1.22 |
| Jun 30, 2023 | -1.08 |
| Mar 31, 2023 | -1.33 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -1.56 |
| Jun 30, 2022 | -1.02 |
| Mar 31, 2022 | -1.01 |
| Dec 31, 2021 | -1.01 |
| Sep 30, 2021 | -0.42 |